CIK 0001437402
- Large accelerated filer
ARDELYX, INC.
Sign in to watch- Ticker
- ARDX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 510-745-7047
- Business address
- 34175 ARDENWOOD BLVD., FREMONT, CA, 94555
- Former names
- NTERYX INC
- 4 Planned sale President & CEO sold 41,666 shares at $5.36 ($223,355)
- 4 Open-market buy Director bought 199,000 shares at $4.99 ($992,672)
- 4 Exercise or conversion Director acquired 100,000 shares (option exercise)
- 4 Planned sale President & CEO sold 41,666 shares at $5.31 ($221,309)
- 4 Exercise or conversion Director acquired 100,000 shares (option exercise)
- 4 Open-market buy Director bought 213,300 shares at $4.67 ($996,580)
- 4 Planned sale President & CEO sold 25,000 shares at $5.26 ($131,620)
- 4 Planned sale President & CEO sold 25,000 shares at $5.38 ($134,483)
- 4 Open-market sale Chief Medical Officer sold 7,366 shares at $4.79 ($35,316)
- 4 Open-market sale Chief Development Officer sold 7,184 shares at $4.79 ($34,444)
- 4 Open-market sale Chief Financial Officer sold 5,260 shares at $4.79 ($25,219)
- 4 Open-market sale President & CEO sold 31,980 shares at $4.79 ($153,328)
- 4 Open-market sale GRAMMER ELIZABETH A sold 7,046 shares at $4.79 ($33,782)
- 4 Open-market sale Blanks Robert sold 4,941 shares at $4.79 ($23,690)
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy Director bought 215,868 shares at $4.62 ($996,598)
- 4 Planned sale President & CEO sold 2,743 shares at $4.90 ($13,441)
- 4 Open-market sale Chief Development Officer sold 27,171 shares at $6.10 ($165,743)
- 4 Open-market sale Chief Development Officer sold 27,172 shares at $5.95 ($161,673)
- 4 Planned sale President & CEO sold 25,000 shares at $5.91 ($147,740)
Page 6 of 35 · 690 filings